Mutual of America Capital Management’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-18,010
Closed -$4.25M 1258
2015
Q1
$4.25M Buy
18,010
+2,284
+15% +$488K 0.09% 296
2014
Q4
$2.98M Buy
15,726
+15,676
+31,352% +$3.48M 0.07% 474
2014
Q3
$12K Buy
+50
New +$10.3K ﹤0.01% 1251

Other funds holding PBYI

Mutual of America Capital Management's PBYI Position: Q2 2015 in Review

Mutual of America Capital Management sold out of Puma Biotechnology (PBYI) in Q2 2015, closing a stake of 18,010 shares — an estimated $4.25M sold.

Mutual of America Capital Management first reported a position in PBYI in Q3 2014 and held it in 3 quarters. The position peaked at $4.25M in Q1 2015. 198 funds tracked by Wall St. Rank hold PBYI as of Q2 2015.

  • Mutual of America Capital Management reported no remaining Puma Biotechnology position as of Q2 2015 after selling out during the quarter.
  • Mutual of America Capital Management sold 18,010 Puma Biotechnology shares in Q2 2015, an estimated $4.25M.
  • Mutual of America Capital Management first reported a position in Puma Biotechnology in Q3 2014 and held it in 3 quarters.
  • Mutual of America Capital Management's Puma Biotechnology position peaked at $4.25M in Q1 2015.
  • 198 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2015.

Based on Mutual of America Capital Management's 13F filing for Q2 2015, filed 5 Aug 2015.